Advertisement
Product › Details
COR-1 (Corimmun)
Next higher product group | cardiovascular drug_o | |
Status | 2010-10-01 development existent | |
Organisation | Corimmun GmbH | |
Group | Johnson & Johnson (JnJ) (Group) | |
Original research | University of Würzburg | |
Record changed: 2023-07-10 |
Advertisement
More documents for cardiovascular drug_o
- [1] Vifor Pharma AG. (11/22/21). "Press Release: Vifor Pharma to Spearhead Development of Vascular Calcification Field, through Acquisition of Sanifit Therapeutics and Inositec AG". St. Gallen, Palma & Zurich....
- [2] Novartis AG. (1/6/20). "Press Release: Novartis Successfully Completes Acquisition of The Medicines Company, Adding a Potentially First-in-Class, Investigational Cholesterol-lowering Therapy Inclisiran". Basel....
- [3] Novartis AG. (1/6/20). "Press Release: Novartis Completes Tender Offer for All Outstanding Shares of The Medicines Company". Basel....
- [4] Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel....
- [5] Omeicos Therapeutics GmbH. (11/2/18). "Press Release: Omeicos Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation". Berlin & Boston, MA....
- [6] Berlin Cures Holding AG. (8/22/18). "Press Release: Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy". Zug....
- [7] Omeicos Therapeutics GmbH. (7/17/18). "Press Release: Omeicos Therapeutics Announces Compelling First-in-Human Data on Lead Compound OMT-28 and Prepares Phase 2 Trial in Atrial Fibrillation". Berlin....
- [8] Omeicos Therapeutics GmbH. (4/27/18). "Press Release: Alexander Gebauer Joins Executive Board of Omeicos Therapeutics and Named CEO and Chairman of Omeicos Ophthalmics". Berlin & Boston, MA....
- [9] Corvidia Therapeutics. (4/25/18). "Press Release: Corvidia Therapeutics Secures $60 Million in Series B Funding to Accelerate Clinical Work". Waltham, MA....
- [10] Corvidia Therapeutics. (3/29/18). "Press Release: Corvidia Therapeutics Appoints Marc de Garidel as Chief Executive Officer". Waltham, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top